Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Buzz on the Bullboards: New Contenders Enter the Fray

Volatility is a hot word among traders these days, but really, did we ever get a break? A recent cannabis rally seems to have plateaued, while the story of crumbling oil prices and the damage caused to the energy sector appears to be in the rear-view mirror as futures recl...

The Untold Story of Supplying the "Streaming Wars"

There has never been a better time to be a part of the “streaming wars”, either as a viewer, contributor or investor. As more people turn to steaming content, providers like Netflix, Disney and Apple are seeing their share prices increase with...

Where’s the Bottom? – Cycles Paint A Clear Picture

Has the selloff ended? When will it end? What will the bottom look like and am I at risk of taking further losses? What should I do? Do you want to take a guess at how many of our friends and family members are calling us over the past week or so asking these questions? Pe...

Clinical Program Started for Agitation with Schizophrenia, Bipolar Disorder

The design of and an opinion on the included studies are provided in an H.C. Wainwright & Co. report. In a Dec. 30 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that BioXcel Therapeutics Inc. (BTAI:NASDAQ) launched its pivotal trial program for...

Buzz on the Bullboards: Rare Metals, Battery Metals, & Cannabis … Oh My!

(Learjet 75 Liberty light jet. Image via Bombardier Inc.) Stock reports resembled an out of control traffic light on a race track this week; one day it’s all green, the next, a line of red. When every day looks crazier than the last and you do n...

NASDAQ Set to Fall 1000pts In Early 2020, and What it Means for Gold

One of our most interesting predictive modeling system is the Adaptive Dynamic Learning (ADL) price modeling system. It is capable of learning from past price data, building price DNA chains and attempting to predict future price activity with a fairly high degree of accuracy....

Progress for radiology drugs and medical imaging company

Voyageur Pharmaceuticals ( TSXV:VM ) ( OTC:VYYRF ) is focused on vertically integrating the barium, iodine and carbon contrast imaging market – think radiology drugs and medical imaging. Its business plan is set to generate immediate cash flow by partnering with thir...

Targa Exploration raising more than $1.3M for Opinaca Project

Targa Exploration Corp. (CSE:TEX) is raising more than C$1.3 million in a non-brokered private placement The financing raise consists of hard dollar and charity flow-through units Targa completed the first tranche of the private placement March 28 for gr...

Standard Lithium Demo Plant Operating Soon, First Production in 2022

This month, Standard Lithium Ltd. (SLL:TSX.V; STLHF:OTCQX) is targeted to switch on a relatively large-scale, proof-of-concept lithium extraction Demonstration Plant in southern Arkansas. If all goes reasonably as planned, it should take just a few months to prove the...

The Revolutionary Co. That’s Breaking Through the Blood Brain Barrier

(Click image to play video) Delivery of therapeutics across the blood-brain barrier (BBB) and into the brain has been the single greatest challenge to treating hundreds of common and rare neurological diseases, including brain cancers, neurodegenerative diseases...
1 2 3 4 5 6